111, Inc. American Depositary Receipt (YI)
NASDAQ
Real-time Data
01:30 PM
Day's Range
3.0952 wk Range
2.48Overview - YI - 111, Inc. American Depositary Receipt
Key Statistics
Valuation
Enterprise Value
133.23M
P/E (Trailing)
‪-0.02‬
P/E (Forward)
‪25.71‬
PEG Ratio
‪-0.00021‬
Price / Sales (TTM)
‪0.0030‬
Price / Book
‪1.16‬
EV / EBITDA
‪-24.46‬
Profitability
Gross Margin
‪5.33%‬
Profit Margin
‪-1.00%‬
Operating Margin
‪-1.01%‬
Return on Assets
‪-1.34%‬
Return on Equity
‪-27.52%‬
Ownership
Shares Outstanding
175.93M
Float
4.65M
Short % of Shares Outstanding
‪0.21%‬
Held by Insiders
‪9.93%‬
Held by Institutions
‪0.61%‬
Price stats
Beta
‪0.65‬
50-Day Avg
‪3.62‬
200-Day Avg
‪5.09‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - YI - 111, Inc. American Depositary Receipt
Peers - YI - 111, Inc. American Depositary Receipt
Peer Comparison
Compared with companies in Medical Distribution listed on NASDAQ.
Profile Summary - YI - 111, Inc. American Depositary Receipt
About
111, Inc. American Depositary Receipt represents the U.S.-traded ownership interest in 111, Inc., a China-based healthcare platform focused on pharmaceutical products and medical services. 111, Inc. operates an integrated online and offline healthcare ecosystem that connects consumers and business customers with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
